Literature DB >> 19362384

A case of fulminant type 1 diabetes with coxsackie B4 virus infection diagnosed by elevated serum levels of neutralizing antibody.

Hajime Akatsuka1, Yutaka Yano, Esteban C Gabazza, John Morser, Ryoma Sasaki, Toshinari Suzuki, Ryoko Fujiwara, Akira Katsuki, Yoshiyuki Takei, Yasuhiro Sumida.   

Abstract

A 39-year-old woman with hyperglycemia and ketonuria but with normal HbA1c level was diagnosed as having fulminant type 1 diabetes. The patient had 8-fold increase in the plasma titer of coxsackie B4 virus neutralizing antibody. Infection with coxsackie B4 virus was associated with fulminant type 1 diabetes.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19362384     DOI： 10.1016/j.diabres.2009.03.009

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN： 0168-8227            Impact factor:   5.602


  9 in total

Review 1.  Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host.

Authors:  Didier Hober; Pierre Sauter
Journal:  Nat Rev Endocrinol       Date:  2010-03-30       Impact factor: 43.330

Review 2.  Fulminant type 1 diabetes in China: a case report and review of the literature.

Authors:  Yun-fei Feng; Mei-fen Yao; Qi Li; Yan Sun; Cheng-jiang Li; Jian-guo Shen
Journal:  J Zhejiang Univ Sci B       Date:  2010-11       Impact factor: 3.066

3.  Viruses and Type 1 diabetes: a dynamic labile equilibrium.

Authors:  Darius A Schneider; Matthias G von Herrath
Journal:  Diabetes Manag (Lond)       Date:  2013-05

Review 4.  The role of innate immune pathways in type 1 diabetes pathogenesis.

Authors:  Steven C Pino; Annie J Kruger; Rita Bortell
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-04       Impact factor: 3.243

Review 5.  Type 1 diabetes: translating mechanistic observations into effective clinical outcomes.

Authors:  Kevan C Herold; Dario A A Vignali; Anne Cooke; Jeffrey A Bluestone
Journal:  Nat Rev Immunol       Date:  2013-04       Impact factor: 53.106

6.  The status of serum γ-interferonand antiviral antibodies in patients with type I and type 2 diabetes: A comparative study.

Authors:  Zhian M I Dezayee
Journal:  J Res Med Sci       Date:  2012-09       Impact factor: 1.852

7.  Class II HLA genotype in fulminant type 1 diabetes: A nationwide survey with reference to glutamic acid decarboxylase antibodies.

Authors:  Chiharu Tsutsumi; Akihisa Imagawa; Hiroshi Ikegami; Hideichi Makino; Tetsuro Kobayashi; Toshiaki Hanafusa
Journal:  J Diabetes Investig       Date:  2012-02-20       Impact factor: 4.232

8.  Fulminant type 1 diabetes mellitus associated with a reactivation of Epstein-Barr virus that developed in the course of chemotherapy of multiple myeloma.

Authors:  Atsushi Fujiya; Hiroshi Ochiai; Toshihiro Mizukoshi; Atsushi Kiyota; Taiga Shibata; Atsushi Suzuki; Norimi Ohashi; Hiroshi Sobajima
Journal:  J Diabetes Investig       Date:  2010-12-03       Impact factor: 4.232

Review 9.  Potential viral pathogenic mechanism in human type 1 diabetes.

Authors:  Darius A Schneider; Matthias G von Herrath
Journal:  Diabetologia       Date:  2014-07-30       Impact factor: 10.122
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.